Internationally known Neuroendocrine Cancer Patient Leader, Ronny Allan, is certainly making his mark in the online health community.
Diagnosed with incurable Metastatic Neuroendocrine Cancer in July 2010, Ronny decided to share his experiences with this unusual, complex disease through blogging. This hobby quickly became a passion as Ronny became determined to move Neuroendocrine Cancer into mainstream knowledge circles. His blog offers factual and educational resources with the occasional pinch of humor in hopes of putting a positive spin on life.
As his blog continued to grow, so did his community. As winner of the 2016 WEGO Health Awards, Best in Show Community, Ronny has fostered a community where patients and caregivers have come to rely on his support, educational resources, and balanced perspective.
#WEGOHealthAwards Winners Series Podcast, Shane Schulz, had the opportunity to sit down with Ronny and discuss how his patient leadership began and how he went on to build the strong community we see today. Be sure to listen to the full interview on Spreaker and iTunes.
With his extensive internet and social media “footprint”, Ronny will tell you it is his purpose now to not only bring awareness to his atypical Cancer but much much more!
3:27 Here is where we Learn why and how Ronny started his award winning blog!
9:34 Ronny tells his story of how he learned he was a cancer patient.
14:09 Are you wondering how a medical information blog can be so popular? Here’s how!
Missed our last WEGO Health podcast? Don’t fret- listen to the full #WEGOHealthAwards Winners Series Podcast here.
Looking to start your own podcast? Check out these 3 basic questions you should be asking yourself before you hit record. And as always, be sure to share your podcast with the WEGO Health Network team.
Kristen Long is the Patient Leader Network Coordinator at WEGO Health. Her own health experiences have inspired her to empower other patients and encourage the power of patient advocacy. Check out her blog and follow Kristen on Twitter and Facebook.